← Leaderboards
John H Van Duzer
Inotek Pharmaceuticals Corporation
$164,737
Attributed
$164,737
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$164,737 · 1
By mechanism
R43$164,737 · 1
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Garry John Southan$13,828,224
- Csaba Szabo$15,264,870
- Andrew L Salzman$19,918,828
- Prakash Jagtap$6,029,479
- Kanneganti Murthy$5,565,701
Others in their field
Top investigators on “Cytoprotection”
- Augustine M Choi · Weill Medical Coll Of Cornell Univ$15,905,527
- Jerzy W. Kupiec-Weglinski · University Of California Los Angeles$15,188,632
- Daniel J. Klionsky · University Of California Davis$14,255,165
- Thomas W Kensler · Johns Hopkins University$12,456,994
- Berislav V Zlokovic · University Of Rochester$12,407,137
- Daria Mochly-Rosen · Stanford University$12,098,136
Research focus
CytoprotectionDrug Design /Synthesis /ProductionDrug Screening /EvaluationEnzyme InhibitorsFree RadicalsMyocardial Ischemia /HypoxiaOxidizing AgentsPentosyltransferaseReperfusionSwine